Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal Hypoglycemia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

NULL HYPOTHESIS • There is no difference in the incidence of hypoglycemia among preterms receiving either two hourly 10% dextrose boluses or 10% dextrose infusion by burettes during the 72 hours of admission in Special Care Unit- Mulago Hospital.

ALTERNATE HYPOTHESIS

• Use of two hourly 10% dextrose boluses increases the incidence of hypoglycemia by 30% compared to 10% dextrose infusion by burettes among preterms admitted to Special Care Unit in the first 72 hours of admission.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dextrose Gel Does Not Prevent Neonatal Hypoglycemia

NCT02523222

Hypoglycemia Infant, Small for Gestational Age Premature Birth of Newborn +4 more

COMPLETED PHASE2/PHASE3

Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission

NCT04085978

Hypoglycemia Neonatal Hypoglycemia

TERMINATED

Prevention of Hypoglycaemia by Oral 40% Destrogel

NCT04185766

Hypoglycaemia Neonatal

COMPLETED NA

The Efficacy of Self-Manufactured 40% Dextrose Gel in Asymptomatic Transient Neonatal Hypoglycemia Treatment

NCT07015450

Neonatal Hypoglycemia

COMPLETED PHASE4

To Examine if the Mother's Glucose Levels and Glucose Levels in the Blood Can Predict Cord Hypoglycemia in Newborns at Risk.

NCT02838875

Neonatal Hypoglycemia

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Once a Preterm Developed Hypoglycemia, no More Blood Glucose Was Measured During the Study Period.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bolus arm

two hourly dextrose boluses administered via an intravenous cannula

Group Type PLACEBO_COMPARATOR

10% dextrose

Intervention Type DRUG

infusion

10% dextrose infusion by burettes

Group Type EXPERIMENTAL

10% dextrose

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

10% dextrose

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Preterms whose care givers/ mothers gave informed consent
* Preterms whose age was \< 24 hours of life
* Preterms with birth weight ≥1kg
* Preterms with random blood sugar ≥ 2.6 mmol/l at admission into SCU.